Novartis | Dochód Netto



Net Income Zmiana Data
AbbVie USD 1.29B 1.31B 2025-03
Alcon AG USD 350M 66M 2025-03
Almirall EUR -5243000 13.23M 2024-12
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Autolus Therapeutics Ltd -70161000 42.55M 2025-03
Bayer EUR 1.3B 1.63B 2025-03
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Fresenius EUR 229M 11M 2025-03
Fresenius Medical Care EUR 151M 84.1M 2025-03
Galapagos EUR -153403000 178.71M 2025-03
Genmab DKK 195M 3.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GRIFOLS EUR 59.72M 9.24M 2025-03
Hikma Pharmaceutical USD 226M 167M 2024-06
J&J USD 11B 7.57B 2025-03
Lonza CHF 329M 85M 2024-06
Merck EUR 667M 142M 2024-12
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Novo Nordisk 29.03B 1.73B 2025-03
Orion EUR 61.2M 12.2M 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Philips EUR 75M 410M 2025-03
Recordati EUR 125.04M 12.01M 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 104M 72M 2024-06



Novartis Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.